REGISTRATION
None identified
PRODUCER
"Australia based" claimed
PRODUCT OPTIONS
444mg tablets, 100 count (fenbendazole)
SUBSIDIARY BRANDS
None identified
INDEPENDENT CERTIFICATE OF ANALYSIS
Park Pharmaceuticals internal CoA
A1 Fenz Cleanse
Full Brand & Product Review
Overall Rating: 2.5 / 10
2026.06.12
Overview
A1 Fenz Cleanse ↗ markets itself as an Australia-based supplier of fenbendazole, targeting consumers following off-label antiparasitic health protocols. The brand runs paid advertising on Facebook and Instagram and presents an Australian identity across all consumer-facing touchpoints.
What the website does not mention is that the product is manufactured in India. This review focuses on the 444mg fenbendazole product. The brand also sells ivermectin 12mg, noted for context only.
Criteria Ratings
1. Information Transparency
Rating: 2/10
No owner, founder, or team member is identified anywhere across the website or any social media profile.
No ABN (Australian Business Number) is disclosed — a mandatory requirement for any business operating in Australia.
The contact email is a Gmail account containing a spelling error in the brand name itself: fenzclease@gmail.com ("cleanse" written as "clease").
The brand operates across at least seven domains with identical content. This multi-domain structure is consistent with an operation designed to survive platform bans and payment processor blocks by distributing across disposable properties. The same product also appears through unrelated-branded domains with identical copy.
Facebook ads for the brand openly disclose "ongoing supply and payment processing challenges" — a direct admission that at least one payment processor has blocked or restricted the account, a pattern consistent with sellers operating in regulatory grey zones.
The Facebook page cover photo and Instagram posts display the full product name "FENBENDAZOLE 444mg Parasite Cleanse" without any abbreviation.
The same brand uses truncated names ("Fen***") in paid Facebook advertising to circumvent automated content moderation — applying platform-specific naming to evade enforcement while maintaining full branding where moderation is weaker.
2. Label Accuracy
Rating: 2/10
The product bottle carries the label "FENBENDAZOLE 444mg Parasite Cleanse." The phrase "Parasite Cleanse" is printed directly on the physical product label — not in surrounding marketing copy.
Under both TGA (Australia) ↗ and FTC (US) ↗ standards, this constitutes a direct therapeutic claim on the label of an unregistered product. This is the most direct label compliance violation identified across all brands in this review series.
The website displays "89 reviews" on the product page. These numbers are not clickable and link to no external platform. They are static design elements — not verified consumer reviews.
No inactive ingredients list, excipient disclosure, or formulation details are published on the website. The CoA (discussed under Section 4) identifies the actual fenbendazole content as 435.4mg, not 444mg as labeled.
This falls within the manufacturer's stated reference range of 399.6–488.4mg, but the discrepancy between the labeled dose and the measured dose is not disclosed to consumers.
3. Product Definition
Rating: 2/10
The product is described as fenbendazole 444mg in tablet form, 100 count. No CAS number, molecular formula is published on the website.
The dosage calculator recommends 20mg of fenbendazole per kilogram of body weight.
For a 75kg person, this equates to 1,500mg per day — approximately six to seven times the 222mg daily dose referenced in the Joe Tippens protocol that the brand's own marketing is built around.
This figure is derived from veterinary dosing guidelines and has no published clinical basis for human use.
Recommending this dosage without medical supervision represents a meaningful safety concern.
The website publishes unverified photos of unidentified organic matter under the heading "Real Results from Real Customers."
Medical professionals consistently identify this type of imagery as misrepresented — what appears in such photos is typically mucus, partially digested food, or other bodily material, not parasites.
Using these images as product efficacy evidence is a documented manipulative practice in the parasite cleanse marketing category.
4. Manufacturer Traceability
Rating: 3/10
The manufacturer was not disclosed on the website and was revealed only in response to a comment on social media.
The CoA, posted by the brand in a comments section rather than on a product page, identifies the manufacturer as Park Pharmaceuticals, Plot No. 272, Industrial Area, Phase II, Panchkula, Haryana, India.
Park Pharmaceuticals is a real, verified contract manufacturing operation established in 2006, listed on IndiaMART as a verified supplier ↗, and holding GMP and ISO 9001 certifications. The product is manufactured under the name FENMEX 444, Batch MI-50062, manufactured January 2025.
This directly contradicts the brand's positioning as "Australia based." The product is manufactured in India and imported. The 7–14 business day delivery timeline is consistent with international shipping from India, not domestic Australian fulfillment.
The CoA is issued under India's Drug & Cosmetics Act 1940, Form 39.
This is Park Pharmaceuticals' own internal quality control document — not an independent third-party laboratory test. "Received from: SELF" and "Mfg by/Sup by: SELF" confirm that Park Pharmaceuticals tested its own product.
The document carries no ISO 17025 accreditation. No independent testing of any kind has been published.
5. Availability & Distribution
Rating: 4/10
The brand sells exclusively through its direct website ↗ network and paid Facebook and Instagram advertising.
No Amazon, eBay, or third-party marketplace presence has been identified.
Delivery is 7–14 business days — consistent with international Indian fulfillment.
The Instagram bio ↗ explicitly states "No Prescription Needed" in reference to Schedule 4 and prescription-regulated compounds under Australian law.
6. Public Feedback Patterns
Rating: 2/10
No Trustpilot profile exists. No independent review platform has any record of this brand.
The website claims "10,000+ happy customers" and "4.9/5 from 500+ reviews."
The Instagram account has 98 followers and 18 posts.
The Facebook page has 499 followers. No brand with a genuine customer base of 10,000+ would have these social media figures after running paid advertising.
The discrepancy directly contradicts the social proof claims used to drive purchases.
Summary Scorecard
Main Conclusion
A1 Fenz Cleanse is an anonymous operation with no ABN, no disclosed ownership, no physical address, and no independent quality documentation.
The product is manufactured in India by Park Pharmaceuticals — a fact disclosed only in a social media comment, not on the website.
The "Australia based" positioning is inconsistent with the evidence. The product label carries a direct therapeutic claim.
The dosage calculator recommends quantities six to seven times above established off-label protocols.
Social proof claims of 10,000+ customers are contradicted by fewer than 100 Instagram followers.
Of all brands reviewed in this series, A1 Fenz Cleanse presents the weakest accountability infrastructure and the highest concentration of regulatory and consumer protection concerns.
